Non-invasive scintigraphic monitoring of gene expression in a hsv-1 thymidine kinase gene therapy model

Nuclear Medicine Communications

Volumn 18, Issue 7, 1997, Pages 599-605

  Morin, K W ^a   Knaus, E E ^a   Wiebe, L I ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 IODOVINYL) 2' DEOXYURIDINE; GANCICLOVIR; GENE PRODUCT; THYMIDINE KINASE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; MOUSE; NONHUMAN; SARCOMA; SCINTIGRAPHY; TUMOR GROWTH;

EID: 0030861693     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199707000-00002     Document Type: Article

References (22)

1. Straus S. Herpes simplex virus infection: Biology, treatment and prevention. Ann Intern Med 1985; 103: 404-419.
2. Moolten FL, Wells JM. Curability of tumors bearing herpes thymidine kinase genes transferred by retrovirus vectors. J Natl Cancer Inst 1990; 82: 297-300.
3. Moolten F. Tumor sensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-5281.
4. Ezzeddine ZT, Martuza RL, Platika D et al. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. New Biol 1991; 3: 608-614.
5. Ohno T, Gordon D, San H et al. Gene therapy for vascular smooth muscle proliferation after arterial injury. Science 1994; 265: 781-784.
6. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993; 4: 60-69.
7. Raffel C, Culver K, Kohn D et al. Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase gene/ganciclovir system. Hum Gene Ther 1994; 5: 863-890.
8. Oldfield EH, Ram Z, Chiang Y, Blaese RM. Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis. GTI 0108. A phase I/II study. Hum Gene Ther 1995; 6: 55-85.
9. Elion GB, Furman PA, Fyfe JA, DeMiranda P, Beauchamp L, Schaeffer HJ. Selectivity of action and cellular toxicity of an antiherpetic agent 9-(2-hydroxyethoxymethyl)guanine. Proc Natl Acad Sci USA 1977; 74: 5716-5720.
10. Descamps J, De Clercq E. Specific phosphorylation of E-5-(2-iodovinyl)-2’-deoxyuridine by herpes simplex virus-infected cells. J Biol Chem 1980; 256: 5973-5976.
11. Tjuvajev JG, Stockhammer G, Desai R et al. Imaging the expression of transfected genes in vivo. Cancer Res 1995; 55: 6126-6132.
12. Tjuvajev JG, Finn R, Watanabe K et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy. Cancer Res 1996; 65: 4087-4095.
13. Iwashina T, Tovell DR, Xu L, Tyrell DL, Knaus EE, Wiebe LI. Synthesis and antiviral activity of IVFRU, a potential probe for the non-invasive diagnosis of herpes simplex encephalitis. Drug Des Del 1988; 3: 309-321.
14. Balzarini J, Morin KW, Knaus EH, Wicbc LI, De Clercq E. Novel (E)-5-(2-iodovinyl)-2’-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors. Gene Ther 1995; 2: 317-322.
15. 3Iliodovinyl)-2-deoxyuridine in dogs. Antimicrob Agents Chemother 1986; 29: 320-324.
16. 125I)iodovinyl)’2’-deoxyuridine in tumor cells transduced with the herpes simplex type-1 thymidine kinase gene: Evaluation as probes for monitoring gene therapy. J Med Chem (in press).
17. Freeman SM, Abboud CN, Whartenby KA et al. The ‘bystander effect’: Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-5283.
18. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. In vivo gene transfer with retroviral vector-pro-ducer cells for treatment of experimental brain tumors. Science 1992; 256: 1550-1552.
19. Bi WL, Parysek LM, Wamick R, Stambrook PJ. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 1993; 4: 725-731.
20. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D. Regression of established macroscropic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 1993; 90: 7024-7028.
21. Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg 1994; 81: 256-260.
22. Plautz G, Nabel EG, Nabel GJ. Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol 1991; 3: 709-715.